Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Pediatric Clinical Practice
Open Label Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Pediatric Clinical Practice
1 other identifier
observational
200
1 country
1
Brief Summary
The purpose of this research study is to evaluate the feasibility in conducting advanced MRI sequences in a pediatric clinical setting. The study will be observational in nature, and will only evaluate the studies of pediatric patients who have already been prescribed an advanced MRI for clinical neurological purposes. The only difference for the subject in participating in this study is that the data and information about their scan can be used and disclosed for research purposes, i.e. understanding if the time of the scan, patient comfort, and quality of the data are feasible. Standard MRI's have been extremely beneficial in the diagnosis and assessment of disease, injury, and anomalies throughout the body. Adding advanced MRI sequences to the arsenal of current standard MRI sequences, as well as analyzing the clinical significance of the data, may improve the benefits of MRI in the future. Within this scope, the study will be looking at the following factors:
- Patient arrival time/lateness
- Patient preparation time
- Time scanner is being occupied
- Patient compliance (is the patient continually stopping the study for breaks, fear, movement, etc.)
- Patient dropout rate, including:
- Change of mind
- Cost of study is too much
- Failure to finish the scan
- Usability of data, including:
- Movement artifact
- Patient requiring re-scan for any reason The scan will consist of two to five advanced MRI sequences that will average between 7-15 minutes each, in addition to a routine 5 minute standard MRI sequence. The variability in the number of advanced sequences depends on the prescription and patient history. All sequences are performed using a 1.5 Tesla Siemens MRI scanner at Westwood Open MRI, a 3 Tesla GE scanner at Tower Saint John's Imaging, or a 3 Tesla Siemens MRI scanner at Resolution Imaging. All scanners are FDA-approved.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 12, 2017
CompletedFirst Posted
Study publicly available on registry
July 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedSeptember 28, 2022
September 1, 2022
8.5 years
June 12, 2017
September 26, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of subjects who successfully complete an fMRI scan
In order to assess scan feasibility, we will keep track of the total number of patients who sign the consent form and are able to complete the fMRI scan.
Through study completion, an average of 1 year
Secondary Outcomes (10)
Subject appointment time vs. subject arrival time
Through study completion, an average of 1 year
Time it takes subject to get from checked-in to start of scan (in minutes)
Through study completion, an average of 1 year
How long was the scanner unoccupied (in minutes)
Through study completion, an average of 1 year
Number and type of sequences performed
Through study completion, an average of 1 year
Time of scan (in minutes)
Through study completion, an average of 1 year
- +5 more secondary outcomes
Eligibility Criteria
The subjects in this research study will be recruited by routine medical office exam.The ages for the subjects in this study will range from neonates to 18 years old.The gender distribution for this study will aim for a ratio of 50:50 male to female. There are no enrollment restrictions based upon race or ethnic origin. There are also no additional benefits, risks, advantages, or disadvantages based off of any race or ethnic origin.
You may qualify if:
- In order for a subject to be considered for this study, the following criteria are required:
- The subject is between the ages of neonate-18 years old
- The subject clinically needs an advanced MRI
- The assent of the subject and the agreement of parent(s) or guardian(s) to the participation of their child or ward in research, in accordance with the regulations set forth in the Belmont Report
You may not qualify if:
- In order for a subject to be considered for this study, he/she may NOT have any of the following items in which cannot be removed prior to the MRI exam. A subject that can remove any of the following prior to the MRI exam will still be considered for the study.
- Aneurism clips
- Cardiac pacemaker
- Implanted cardioinverter defibrillator
- Electronic implant or device
- Magnetically activated implant or device
- Neurostimulation system
- Spinal cord stimulator
- Internal electrodes or wires
- Bone growth/bone fusion stimulator
- Cochlear, otologic, or other ear implant
- Insulin or other infusion pump
- Implanted drug infusion device
- Any type of prosthesis (eye, penile, etc.)
- Heart valve prosthesis
- +38 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neurological Associates of West Los Angeles
Santa Monica, California, 90403, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sheldon Jordan, MD, FAAN
Neurological Associates of West Los Angeles
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neurologist
Study Record Dates
First Submitted
June 12, 2017
First Posted
July 28, 2017
Study Start
July 1, 2016
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
September 28, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share